Orchard Therapeutics (ORTX) PT Lowered to $20 at Wedbush

May 7, 2020 4:12 PM EDT
Get Alerts ORTX Hot Sheet
Price: $2.82 -1.05%

Rating Summary:
    9 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten lowered the price target on Orchard Therapeutics (NASDAQ: ORTX) to $20.00 (from $22.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change